Targeting mutant estrogen receptors
Year: 2019
Type: article
Abstract: A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.
Source: eLife
DOI: 10.7554/elife.44181
Institution: Duke University
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,500
OpenAlex ID: W2908980762
